Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Disease Progression. Found 43 abstracts

no pagination
Aras S, Zaidi MR. TAMeless traitors: macrophages in cancer progression and metastasis. Br J Cancer. 2017 Oct 24;117(11):1583-91.   PMCID: PMC5729447
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. The New England journal of medicine. 2017 Aug 17;377(7):644-57.
Zahid MF, Khan N, Hashmi SK, Kizilbash SH, Barta SK. Central nervous system prophylaxis in diffuse large B-cell lymphoma. Eur J Haematol. 2016 Aug;97(2):108-20.
Zhao S, Tang H, Yan D, Fan J, Sun H, Wen Y, Yu F, Cui F, Zhang D, Xue Y, Liu C, Yue B, Chen J, Wang J, Wang X, Zhang M, Yu Y, Jiang W, Liu X, Mi Y, Zhou Z, Qin X, Peng Z. DDA1 promotes stage IIB-IIC colon cancer progression by activating NFkappaB/CSN2/GSK-3beta signaling. Oncotarget. 2016 Apr 12;7(15):19794-812.   PMCID: PMC4991419
Bassi DE, Cenna J, Zhang J, Cukierman E, Klein-Szanto AJ. Enhanced aggressiveness of benzopyrene-induced squamous carcinomas in transgenic mice overexpressing the proprotein convertase PACE4 (PCSK6). Mol Carcinog. 2015 Oct;54(10):1122-31.   PMCID: PMC4240754
Foy JP, Pickering CR, Papadimitrakopoulou VA, Jelinek J, Lin SH, William WN, Frederick MJ, Wang J, Lang W, Feng L, Zhang L, Kim ES, Fan YH, Hong WK, El-Naggar AK, Lee JJ, Myers JN, Issa JP, Lippman SM, Mao L, Saintigny P. New DNA Methylation Markers and Global DNA Hypomethylation Are Associated with Oral Cancer Development. Cancer prevention research (Philadelphia, Pa). 2015 Nov;8(11):1027-35.   PMCID: 4777304
Ito T, Kutikov A. Kidney cancer in 2014: Key advances promise progress for kidney cancer patients. Nature reviews Urology. 2015 Feb;12(2):69-70.
Ito T, Kutikov A. Kidney cancer in 2014: Key advances promise progress for kidney cancer patients. Nature reviews Urology. 2015 Feb;12(2):69-70.
Kelly JL, Salles G, Goldman B, Fisher RI, Brice P, Press O, Casasnovas O, Maloney DG, Soubeyran P, Rimsza L, Haioun C, Xerri L, LeBlanc M, Tilly H, Friedberg JW. Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies. J Clin Oncol. 2015 May;33(13):1482-90.   PMCID: PMC4404425
Kwon Y, Smith BD, Zhou Y, Kaufman MD, Godwin AK. Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment. Oncogene. 2015 Jan;34(2):144-53.   PMCID: PMC4067476
Masica DL, Li S, Douville C, Manola J, Ferris RL, Burtness B, Forastiere AA, Koch WM, Chung CH, Karchin R. Predicting survival in head and neck squamous cell carcinoma from TP53 mutation. Hum Genet. 2015 May;134(5):497-507.   PMCID: 4324386
Mehrazin R, Smaldone MC, Egleston B, Tomaszewski JJ, Concodora CW, Ito TK, Abbosh PH, Chen DY, Kutikov A, Uzzo RG. Is anatomic complexity associated with renal tumor growth kinetics under active surveillance?. Urologic Oncology: Seminars and Original Investigations. 2015 Apr;33(4):167e7-167e12.   PMCID: PMC4417444
Motzer RJ, Rini BI, McDermott DF, Redman BG, Kuzel TM, Harrison MR, Vaishampayan UN, Drabkin HA, George S, Logan TF, Margolin KA, Plimack ER, Lambert AM, Waxman IM, Hammers HJ. Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial. J Clin Oncol. 2015 May;33(13):1430-7.   PMCID: PMC4806782
Zeisel MB, Lucifora J, Mason WS, Sureau C, Beck J, Levrero M, Kann M, Knolle PA, Benkirane M, Durantel D, Michel ML, Autran B, Cosset FL, Strick-Marchand H, Trepo C, Kao JH, Carrat F, Lacombe K, Schinazi RF, Barre-Sinoussi F, Delfraissy JF, Zoulim F. Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure. Gut. 2015 Aug;64(8):1314-26.
Obeid EI, Conzen SD. The role of adrenergic signaling in breast cancer biology. Cancer Biomark. 2013 Jan;13(3):161-9.
Fernandez SV, Snider KE, Wu YZ, Russo IH, Plass C, Russo J. DNA methylation changes in a human cell model of breast cancer progression. Mutat Res. 2010 Jun;688(1-2):28-35.   PMCID: PMC2872054
Xu XZ, Garcia MV, Li TY, Khor LY, Gajapathy RS, Spittle C, Weed S, Lessin SR, Wu H. Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression. Mod Pathol. 2010 Feb;23(2):187-96.   PMCID: PMC2827925
Plimack ER, Tannir N, Lin E, Bekele BN, Jonasch E. Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon: impact of therapy on recurrence patterns and outcome measures. Cancer. 2009 May;115(9):1859-66.
Crispen PL, Viterbo R, Fox EB, Greenberg RE, Chen DY, Uzzo RG. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer. 2008 Mar;112(5):1051-7.
Crispen PL, Wong YN, Greenberg RE, Chen DY, Uzzo RG. Predicting growth of solid renal masses under active surveillance. Urol Oncol. 2008 Sep;26(5):555-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Disease Progression

Disease Progression pathology Female therapeutic use drug therapy Male genetics Middle Aged Renal Cell Carcinoma Kidney Neoplasms Aged Neoplasm Metastasis metabolism Disease-Free Survival adverse effects Antineoplastic Combined Chemotherapy Protocols Tumor Cell Line administration & dosage Treatment Outcome drug effects methods Carcinogenesis etiology Angiogenesis Inhibitors Signal Transduction surgery Proportional Hazards Models prevention & control Cell Proliferation Prognosis Squamous Cell Carcinoma mortality epidemiology Time Factors pharmacology analysis antagonists & inhibitors Pyrimidines physiopathology 80 and over Aged Tumor Microenvironment Mice Organ Sparing Treatments Sulfonamides Retrospective Studies Kaplan-Meier Estimate Breast Neoplasms Rituximab Recurrence immunology Cell Line therapy complications Nephrons Nephrectomy Monoclonal Antibodies Incidence DNA Methylation physiology Skin Neoplasms Adult Nude Mice Risk Factors Indoles Pyrroles Precancerous Conditions HCT116 Cells blood Vitamin D Deficiency bezo(a)pyrene Cell Communication Fibroblasts Nevus skin carcinogenesis Glomerular Filtration Rate radiography NF-kappa B IGF Type 1 Receptor Active surveillance Global Health central nervous system prophylaxis Intravenous Administration Finland Carcinogens Immunohistochemistry Spinal Injections Canada Liver Neoplasms Hospitalization Renal cell carcinoma dosage Aminopyridines Anilides Liver Cirrhosis Foot Follow-Up Studies Tandem Mass Spectrometry Renal tumor Nephrometry Score squamous cell carcinoma DNA-Binding Proteins Prospective Studies biosynthesis Viral DNA Prednisone Adrenergic beta-Antagonists Algorithms Colonic Neoplasms Neoplastic Gene Expression Regulation Italy Hepatitis B virus statistics & numerical data Hepatocellular Carcinoma Heterologous Transplantation Fluorouracil Chronic Hepatitis B CpG Islands United States Mouth Neoplasms tumor progression Postoperative Period Kaplan-Meiers Estimate Polymerase Chain Reaction administration & DNA Sequence Analysis diffuse large B-cell lymphoma Fluorescence In Situ Hybridization Biomarkers Watchful Waiting diagnosis Amputation chemically induced enzymology Adrenergic Receptors-beta CD274 Antigens Drug Dose-Response Relationship COP9 Signalosome Complex Interferon-alpha Central Nervous System Neoplasms HT29 Cells NFkappaB Genetic Promoter Regions Pathologic Neovascularization Angiotensin Receptor-Type 1 Computational Biology Tumor complexity tumor recurrence Neuregulin-1 Type 2 Diabetes Mellitus
Last updated on Friday, February 02, 2018